Fourth Quarter and Full Year 2019 Results Call 02 March 2020 Forward Looking Statements This presentation contains certain forward-looking information about Ziopharm Oncology, Inc. that is intended to be covered by the safe harbor for "forward-looking statements" provided by the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historical facts, and in some cases can be identified by terms such as "may," "will," "could," "expects," "plans," ...

ZIOPHARM Oncology, Inc. (ZIOP) Q4 2019 Results Conference Call March 2, 2020 4:30 PM ET Company Participants Chris Taylor - Vice President, Investor Relations and Corporate Communications Laurence Cooper - Chief Executive Officer Sath Shukla - Executive Vice President, Chief Financial Officer David Mauney - President Conference Call Participants Yale Jen - Laidlaw & Company Thomas Flaten - Lake Street Capital Swayampakula Ramakanth - H.C. Wainwright Nick Abbott - Wells Fargo Operator Ladies and gentlemen, t ...

38th Annual JP Morgan Healthcare Conference 16 January 2020 Forward Looking Statements This presentation contains certain forward-looking information about Ziopharm Oncology, Inc. that is intended to be covered by the safe harbor for "forward-looking statements" provided by the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historical facts, and in some cases can be identified by terms such as "may," "will," "could," "expects," "plans," " ...

| --- | --- | |---------------------------------------------|-------| | | | | | | | | | | | | | Third Quarter Results and Corporate Update | | | November 7, 2019 | | Forward Looking Statement 2 This presentation contains certain forward-looking information about Ziopharm Oncology, Inc. that is intended to be covered by the safe harbor for "forward-looking statements" provided by the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historica ...

ZIOPHARM Oncology, Inc. (ZIOP) Q3 2019 Earnings Conference Call November 7, 2019 4:30 PM ET Company Participants Chris Taylor - Vice President of Investor Relations and Corporate Communications Dr. Laurence Cooper - Chief Executive Officer Dr. David Mauney - President Satyavrat Shukla - Chief Financial Officer Conference Call Participants David Novak - Raymond James Thomas Flaten - Lake Street Capital Sean Lee - H.C. Wainwright Operator Good afternoon, ladies and gentlemen. Thank you for standing by and wel ...

ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) Q2 2019 Earnings Conference Call August 8, 2019 8:30 AM ET Company Participants Christopher Taylor - VP, IR David Mauney - President Laurence Cooper - Chief Executive Officer Satyavrat Shukla - EVP and Chief Financial Officer Drew Deniger - Director of TCR Program Conference Call Participants David Novak - Raymond James Thomas Flaten - Lake Street Capital I-Eh Jen - Laidlaw Sean Lee - H.C. Wainwright Operator Good morning, ladies and gentlemen, and welcome to the Ziopha ...

1 Ziopharm o n c o l o g y Jefferies 2019 Global Healthcare Conference June 6, 2019 Forward Looking Statement 2 This presentation contains certain forward-looking information about Ziopharm Oncology, Inc. that is intended to be covered by the safe harbor for "forward-looking statements" provided by the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historical facts, and in some cases can be identified by terms such as "may," "will," "coul ...

ZIOPHARM Oncology, Inc. (ZIOP) Q1 2019 Earnings Conference Call May 8, 2019 4:30 PM ET Company Participants Christopher Taylor - VP, IR David Mauney - President Laurence Cooper - CEO & Director Conference Call Participants Reni Benjamin - Raymond James & Associates Eric Joseph - JPMorgan Chase & Co. Swayampakula Ramakanth - H.C. Wainwright & Co. I-Eh Jen - Laidlaw & Company Thomas Flaten - Lake Street Capital Markets Operator Good afternoon, ladies and gentlemen, and welcome to the Ziopharm Oncology First Q ...

ZIOPHARM Oncology, Inc. (ZIOP) Q4 2018 Earnings Conference Call March 5, 2019 4:30 PM ET Company Participants David Connolly - IR Laurence Cooper - CEO David Mauney - President Conference Call Participants Reni Benjamin - Raymond James Eric Joseph - J.P. Morgan Sean Lee - H. C. Wainwright Operator Good day, ladies and gentlemen, and welcome to the Ziopharm Fourth Quarter 2018 Earnings Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and ins ...